Global Biomarker Clinical Phase Outsourcing Services Market Size, Share, and COVID-19 Impact Analysis, By Biomarker Type (Surrogate Endpoints, Predictive Biomarker, Prognostic Biomarker, Safety Biomarker, and Others), By Therapeutic Area (Oncology, Neurology, Cardiology, Autoimmune Diseases, and Others), By End-User (Pharmaceutical Companies, Biotechnology Companies, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 - 2033
Industry: HealthcareNeed help to buy this report?
Inquiry Before Buy